Evidence map›Paper›PMID 28336568›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2017

Cholinergic, But Not Dopaminergic or Noradrenergic, Enhancement Sharpens Visual Spatial Perception in Humans.

Caterina Gratton, Sahar Yousef, Esther Aarts, Deanna L Wallace, Mark D'Esposito, Michael A Silver

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Boosting Learning Efficacy with Noninvasive Brain Stimulation in Intact and Brain-Damaged Humans.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Cholinergic modulation of sensory perception and plasticity.Neuroscience and biobehavioral reviews · 2023
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Neuromodulation of prefrontal cortex cognitive function in primates: the powerful roles of monoamines and acetylcholine.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Review
  20. Neurochemistry of Visual Attention.Frontiers in neuroscience · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Caterina GrattonNeurology Department, Washington University, St. Louis, Missouri 63110, cgratton@wustl.edu.ORCID 0000-0003-4607-7401
Sahar YousefSchool of Optometry, University of California, Berkeley, California 94720.ORCID 0000-0003-0199-3481
Esther AartsDonders Institute, Centre for Cognitive Neuroimaging, Radboud University, Nijmegen 6525 EN, The Netherlands.ORCID 0000-0001-6360-6200
Deanna L WallaceDepartment of Neurosurgery, University of California, San Francisco, California 94122, and.
Mark D'EspositoHelen Wills Neuroscience Institute, University of California, Berkeley, California 94720.ORCID 0000-0002-3462-006X
Michael A SilverSchool of Optometry, University of California, Berkeley, California 94720.ORCID 0000-0002-7145-5657
University of California, Berkeley · USRadboud University Nijmegen · NLUniversity of California, San Francisco · USWashington University in St. Louis · US

Funding

UC Berkeley Vision Science COREP30EY003176 · NEI · UNIVERSITY OF CALIFORNIA BERKELEY · PI RICHARD H KRAMER · 1985 to 2026
$16.4M
Effects of attention and acetylcholine on cortical stimulus representationsR01EY025278 · NEI · UNIVERSITY OF CALIFORNIA BERKELEY · PI SILVER, MICHAEL A · 2016 to 2020
$1.8M
Isolating the Extinction Circuit for Cocaine SeekingR01DA034684 · NIDA · UNIVERSITY OF IOWA · PI LALUMIERE, RYAN T · 2013 to 2017
$1.7M
NEI NIH HHS P30 EY003176NEI NIH HHS R01 EY025278NIDA NIH HHS R01 DA034684
6 · The paper itself

Abstract

The neuromodulator acetylcholine modulates spatial integration in visual cortex by altering the balance of inputs that generate neuronal receptive fields. These cholinergic effects may provide a neurobiological mechanism underlying the modulation of visual representations by visual spatial attention. However, the consequences of cholinergic enhancement on visuospatial perception in humans are unknown. We conducted two experiments to test whether enhancing cholinergic signaling selectively alters perceptual measures of visuospatial interactions in human subjects. In Experiment 1, a double-blind placebo-controlled pharmacology study, we measured how flanking distractors influenced detection of a small contrast decrement of a peripheral target, as a function of target-flanker distance. We found that cholinergic enhancement with the cholinesterase inhibitor donepezil improved target detection, and modeling suggested that this was mainly due to a narrowing of the extent of facilitatory perceptual spatial interactions. In Experiment 2, we tested whether these effects were selective to the cholinergic system or would also be observed following enhancements of related neuromodulators dopamine or norepinephrine. Unlike cholinergic enhancement, dopamine (bromocriptine) and norepinephrine (guanfacine) manipulations did not improve performance or systematically alter the spatial profile of perceptual interactions between targets and distractors. These findings reveal mechanisms by which cholinergic signaling influences visual spatial interactions in perception and improves processing of a visual target among distractors, effects that are notably similar to those of spatial selective attention.

Indexed as

Adrenergic alpha-2 Receptor AgonistsAdultBromocriptineCholinesterase InhibitorsContrast SensitivityDonepezilDopamine AgonistsFemaleGuanfacineHumansIndansMalePiperidinesRandom AllocationVisual CortexAdrenergic alpha-2 Receptor AgonistsBromocriptineCholinesterase InhibitorsDonepezilDopamine AgonistsGuanfacineIndansPiperidinesacetylcholineattentiondopaminenorepinephrinepharmacologyvisuospatial perception

Identifiers

PMID28336568
PMCPMC5413181
OpenAlexW2600289562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.